Delivery Order SPE2DB24D2205-SPE2DB25FEEYL
- Not listed
- The Defense Logistics Agency awarded a $13,172.65 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen injectors with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injections valued at $7,989.68. This competitively awarded, firm fixed-price delivery order is scheduled for completion by September 12, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The contract carries no set-aside designation, reflecting the contractor's demonstrated capability to compete in...
- The Defense Logistics Agency awarded a $3,069.43 delivery order to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections with an ultimate completion date of June 2, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,360.45 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mounjaro 15 mg/0.5 mL pen injections on July 22, 2025, with an ultimate completion date of July 23, 2025. The contract, which carries no set-aside designation, will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply relationship with the federal...
- The Defense Logistics Agency awarded a $3,874.78 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mounjaro 12.5 mg/0.5 ml pen injectors in 0.5 ml quantities. This is a competitive award with no set-aside designation, with performance to be completed by August 29, 2025, at the contractor's facility in Conshohocken, Pennsylvania. As a child delivery order under a larger contract vehicle, this award represents a single transaction within...
- The Defense Logistics Agency awarded a delivery order valued at $4,541.93 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injections on April 24, 2025, with completion expected by April 25, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a competitively awarded pharmaceutical supply under the company's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 12.5 mg/0.5 mL pen injectors on August 28, 2025, with a ceiling value of $5,441.80. This non-competitive delivery order, valued at firm fixed price, is set to be completed by August 29, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania facility. The award represents a single delivery transaction under the company's existing contract vehicle with the DLA....
- The Defense Logistics Agency awarded a delivery order valued at $1,225.77 to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Mounjaro 5 mg/0.5 mL pens. This is a firm fixed-price delivery order with an ultimate completion date of July 30, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The Defense Logistics Agency awarded a $2,029.53 delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Mounjaro 5 mg/0.5 mL pen injections (0.5 mL units). This firm fixed-price delivery order, with an ultimate completion date of September 4, 2025, represents a single transaction under AmerisourceBergen's broader pharmaceutical supply agreement with the federal government. The contract carries no set-aside designation and will be performed at the contractor's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen injections valued at $16,657.00, with a completion date of July 1, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively to the pharmaceutical distributor's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of AmerisourceBergen's role as a critical vendor within the DLA's...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEEYLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $13,101.94 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pen injections on July 16, 2025, with a completion date of July 17, 2025. This firm fixed price, competitively awarded delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's existing contract vehicle with DLA. This delivery order is a child award under AmerisourceBergen Drug Corp's Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The parent contract serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs and other federal customers, including the Defense Health Agency and U.S. Coast Guard. Mounjaro, a diabetes medication, exemplifies the specialized pharmaceutical commodities routinely procured through this contract vehicle to support military medical readiness and beneficiary healthcare needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.1k | 7/16/25 |